CA49982-3 - 0x0000000000006A53

Healthy Males & Females

Twilight

* Stipend may pay up to reflected amount.
Start Date: 
December 8, 2026 - 1:15pm
End Date: 
December 18, 2026 - 8:15am

Study Details

Study Number: CA49982
Group Number: 3
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00

Study Criteria

Age: 19 - 60
BMI: 19 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to treat excessive sleepiness in people who work overnights.
Route of Administration: Oral
Blood Draws: 21

Study Schedule

Schedule Type: Short stays with returns
Study Length: 3 - Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Tuesday 12/1/2026
Friday 12/4/2026
Monday 12/7/2026

Doctor Exam Dates:

Event Day Event Date
Tuesday 12/1/2026
Friday 12/4/2026
Monday 12/7/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 12/8/2026 1:15:00 PM Friday 12/11/2026 10:45:00 AM 1 Lincoln
Return Friday 12/18/2026 6:45:00 AM Friday 12/18/2026 8:15:00 AM 1 Lincoln